(Q38305406)

2 September 2017

The structure of an asymmetric dimer relevant to the mode of action of the glycopeptide antibiotics (English)

1 reference

2 September 2017

0 references

Groves P

1

1 reference

2 September 2017

Searle MS

series ordinal

2

1 reference

2 September 2017

Mackay JP

series ordinal

3

1 reference

2 September 2017

Williams DH

series ordinal

4

1 reference

2 September 2017

1 August 1994

1 reference

2 September 2017

1 reference

2 September 2017

2

1 reference

2 September 2017

747-754

1 reference

2 September 2017

8

1 reference

Structural and mode of action studies on the antibiotic vancomycin. Evidence from 270-MHz proton magnetic resonance

2 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2894%2900075-1

7 January 2021

Studies on bacterial cell wall inhibitors. VIII. Mode of action of a new antibiotic, azureomycin B, in Bacillus cereus T

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2894%2900075-1

7 January 2021

Complexation of acetyl-D-alanyl-D-alanine by antibiotic A35512B

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2894%2900075-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0969-2126%2894%2900075-1

1 reference

7 January 2021

In-vitro effects of vancomycin, rifampicin, and fusidic acid, alone and in combination, against methicillin-resistant Staphylococcus aureus.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2894%2900075-1

7 January 2021

Resistance of enterococci to glycopeptides

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2894%2900075-1

7 January 2021

Pristinamycin for Enterococcus faecium resistant to vancomycin and gentamicin

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2894%2900075-1

7 January 2021

Vancomycin resistance in south London

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2894%2900075-1

7 January 2021

Identification of vancomycin resistance protein VanA as a D-alanine:D-alanine ligase of altered substrate specificity.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2894%2900075-1

7 January 2021

The structure and mode of action of glycopeptide antibiotics of the vancomycin group

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2894%2900075-1

7 January 2021

Modifications of the acyl-d-alanyl-d-alanine terminus affecting complex-formation with vancomycin

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2894%2900075-1

7 January 2021

Glycopeptide Antibiotic Activity and the Possible Role of Dimerization: A Model for Biological Signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2894%2900075-1

7 January 2021

Signal transduction by receptors with tyrosine kinase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2894%2900075-1

7 January 2021

Three-dimensional structures of the ligand-binding domain of the bacterial aspartate receptor with and without a ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2894%2900075-1

7 January 2021

Signal transmission by epidermal growth factor receptor: coincidence of activation and dimerization

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2894%2900075-1

7 January 2021

Controlling signal transduction with synthetic ligands

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2894%2900075-1

7 January 2021

Real-time measurements of kinetics of EGF binding to soluble EGF receptor monomers and dimers support the dimerization model for receptor activation

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2894%2900075-1

7 January 2021

Ligand-induced activation of chimeric receptors between the erythropoietin receptor and receptor tyrosine kinases

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2894%2900075-1

7 January 2021

Why are secondary metabolites (natural products) biosynthesized?

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2894%2900075-1

7 January 2021

Genetics and mechanisms of glycopeptide resistance in enterococci

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2894%2900075-1

7 January 2021

Synthesis and antibacterial activity of N-acyl vancomycins

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2894%2900075-1

7 January 2021

Synthesis and antibacterial evaluation of N-alkyl vancomycins

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2894%2900075-1

7 January 2021

Structure-activity relationships of vancomycin-type glycopeptide antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2894%2900075-1

7 January 2021

10.1016/S0969-2126(94)00075-1

Identifiers

DOI

1 reference

2 September 2017

1 reference